MichaelThomasSchweizerMD

PubMed

• Clinical determinants for successful circulating tumor DNA analysis in prostate cancer.
  Schweizer, M. T.,Gulati, R.,Beightol, M.,Konnick, E. Q.,Cheng, H. H.,Klemfuss, N.,De Sarkar, N.,Yu, E. Y.,Montgomery, R. B.,Nelson, P. S.,Pritchard, C. C.> ;Prostate. 2019 Mar 14
• A Phase I Study to Assess the Safety and Cancer-Homing Ability of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Men with Localized Prostate Cancer.
  Schweizer, M. T.,Wang, H.,Bivalacqua, T. J.,Partin, A. W.,Lim, S. J.,Chapman, C.,Abdallah, R.,Levy, O.,Bhowmick, N. A.,Karp, J. M.,De Marzo, A.,Isaacs, J. T.,Brennen, ...> ;Stem Cells Transl Med. 2019 Feb 09
• Differential Response to Olaparib Treatment Among Men with Metastatic Castration-resistant Prostate Cancer Harboring BRCA1 or BRCA2 Versus ATM Mutations.
  Marshall, C. H.,Sokolova, A. O.,McNatty, A. L.,Cheng, H. H.,Eisenberger, M. A.,Bryce, A. H.,Schweizer, M. T.,Antonarakis, E. S.> ;Eur. Urol.. 2019 Feb 25
• Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer.
  Nava Rodrigues, D.,Rescigno, P.,Liu, D.,Yuan, W.,Carreira, S.,Lambros, M. B.,Seed, G.,Mateo, J.,Riisnaes, R.,Mullane, S.,Margolis, C.,Miao, D.,Miranda, S.,Dolling, D.,...> ;J. Clin. Invest.. 2018 Sep 05
• Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study.
  Teply, B. A.,Wang, H.,Luber, B.,Sullivan, R.,Rifkind, I.,Bruns, A.,Spitz, A.,DeCarli, M.,Sinibaldi, V.,Pratz, C. F.,Lu, C.,Silberstein, J. L.,Luo, J.,Schweizer, M. T.,...> ;Lancet Oncol.. 2017 Dec 19
• Supraphysiologic Testosterone Therapy in the Treatment of Prostate Cancer: Models, Mechanisms and Questions.
  Mohammad, O. S.,Nyquist, M. D.,Schweizer, M. T.,Balk, S. P.,Corey, E.,Plymate, S.,Nelson, P. S.,Mostaghel, E. A.> ;Cancers (Basel). 2017 Dec 07
• MSH2 Loss in Primary Prostate Cancer.
  Guedes, L.,Antonarakis, E. S.,Schweizer, M. T.,Mirkheshti, N.,Almutairi, F.,Park, J. C.,Glavaris, S. A.,Hicks, J. L.,Eisenberger, M. A.,De Marzo, A. M.,Epstein, J. I.,...> ;Clin. Cancer Res.. 2017 Aug 10
• Bipolar Androgen Therapy: A Paradoxical Approach for the Treatment of Castration-resistant Prostate Cancer.
  Schweizer, M. T.,Antonarakis, E. S.,Denmeade, S. R.> ;Eur. Urol.. 2017 Apr 04
• Mismatch repair deficiency may be common in ductal adenocarcinoma of the prostate.
  Schweizer MT, Cheng HH, Tretiakova MS, Vakar-Lopez F, Klemfuss N, Konnick EQ, Mostaghel EA, Nelson PS, Yu EY, Montgomery B, True LD, Pritchard CC> ;Oncotarget. 2016-10-15
• A Pilot Study of Clinical Targeted Next Generation Sequencing for Prostate Cancer: Consequences for Treatment and Genetic Counseling.
  Cheng HH, Klemfuss N, Montgomery B, Higano CS, Schweizer MT, Mostaghel EA, McFerrin LG, Yu EY, Nelson PS, Pritchard CC> ;Prostate. 2016-10-01
• Docetaxel-related toxicity in metastatic hormone-sensitive and metastatic castration-resistant prostate cancer.
  Schweizer MT, Gulati R, Mostaghel EA, Nelson PS, Montgomery RB, Yu EY, Cheng HH> ;Med. Oncol.. 2016-07-01
• Bipolar androgen therapy for men with androgen ablation naïve prostate cancer: Results from the phase II BATMAN study.
  Schweizer, M. T.,Wang, H.,Luber, B.,Nadal, R.,Spitz, A.,Rosen, D. M.,Cao, H.,Antonarakis, E. S.,Eisenberger, M. A.,Carducci, M. A.,Paller, C.,Denmeade, S. R.> ;Prostate. 2016 Jun 25
• Targeting persistent androgen receptor signaling in castration-resistant prostate cancer.
  Graham L, Schweizer MT> ;Med. Oncol.. 2016-05-01
• Liquid biopsy: Clues on prostate cancer drug resistance.
  Schweizer, M. T.,Antonarakis, E. S.> ;Sci Transl Med. 2015 Nov 06
• Optimal sequencing of docetaxel and abiraterone in men with metastatic castration-resistant prostate cancer.
  Maughan, B. L.,Xhou, X. C.,Suzman, D. L.,Nadal, R.,Bassi, S.,Schweizer, M. T.,Antonarakis, E. S.> ;Prostate. 2015 Aug 27
• Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: results from a pilot clinical study.
  Schweizer MT Antonarakis ES Wang H Ajiboye AS Spitz A Cao H Luo J Haffner MC Yegnasubramanian S Carducci MA Eisenberger MA Isaacs JT Denmeade SR> ;Sci Transl Med. 2015 Jan 7
• Clinical activity of enzalutamide in Docetaxel-naïve and Docetaxel-pretreated patients with metastatic castration-resistant prostate cancer.
  Nadal, R.,Zhang, Z.,Rahman, H.,Schweizer, M. T.,Denmeade, S. R.,Paller, C. J.,Carducci, M. A.,Eisenberger, M. A.,Antonarakis, E. S.> ;Prostate. 2014 Sep 02
• Clinical activity of enzalutamide versus docetaxel in men with castration-resistant prostate cancer progressing after abiraterone.
  Suzman, D. L.,Luber, B.,Schweizer, M. T.,Nadal, R.,Antonarakis, E. S.> ;Prostate. 2014 Jul 24
• Small cell carcinoma of the prostate.
  Nadal, R.,Schweizer, M.,Kryvenko, O. N.,Epstein, J. I.,Eisenberger, M. A.> ;Nat Rev Urol. 2014 Feb 19
• The Influence of Prior Abiraterone Treatment on the Clinical Activity of Docetaxel in Men with Metastatic Castration-resistant Prostate Cancer.
  Schweizer, M. T.,Zhou, X. C.,Wang, H.,Bassi, S.,Carducci, M. A.,Eisenberger, M. A.,Antonarakis, E. S.> ;Eur. Urol.. 2014 Feb 05
• Chemotherapy and its evolving role in the management of advanced prostate cancer.
  Schweizer, M. T.,Antonarakis, E. S.> ;Asian J. Androl.. 2014 Jan 18
• Immunotherapy for prostate cancer: recent developments and future challenges.
  Schweizer, M. T.,Drake, C. G.> ;Cancer Metastasis Rev.. 2014 Jan 31
• Metastasis-free survival is associated with overall survival in men with PSA-recurrent prostate cancer treated with deferred androgen deprivation therapy.
  Schweizer MT Zhou XC Wang H Yang T Shaukat F Partin AW Eisenberger MA Antonarakis ES> ;Ann Oncol. 2013 Nov
• Adjuvant leuprolide with or without docetaxel in patients with high-risk prostate cancer after radical prostatectomy (TAX-3501): Important lessons for future trials.
  Schweizer, M. T.,Huang, P.,Kattan, M. W.,Kibel, A. S.,de Wit, R.,Sternberg, C. N.,Epstein, J. I.,Eisenberger, M. A.> ;Cancer. 2013 Oct 15
• Pharmacodynamic study of disulfiram in men with non-metastatic recurrent prostate cancer.
  Schweizer, M. T.,Lin, J.,Blackford, A.,Bardia, A.,King, S.,Armstrong, A. J.,Rudek, M. A.,Yegnasubramanian, S.,Carducci, M. A.> ;Prostate Cancer Prostatic Dis.. 2013 Aug 20
• Join now to see all

Lectures

• Genomic characterization of ductal adenocarcinoma of the prostate. 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018